Mohammed Hamdan Hameed Alsubhi
Research Interest
My research focuses on cancer pharmacology and pharmacogenomics, specifically targeting treatment resistance in solid tumours. I aim to understand the molecular and genetic mechanisms that drive resistance to cancer therapies, identifying biomarkers that predict response to treatment. This research is pivotal in overcoming treatment resistance, ultimately leading to better clinical outcomes and quality of life for cancer patients.
